Latest News
PPG Industries has underperformed the Materials industry over the past year, but analysts are cautiously optimistic about the stock’s prospects.
Via Barchart.com · December 8, 2025
Via Benzinga · December 8, 2025
Via Benzinga · December 8, 2025
Via Benzinga · December 8, 2025
GE Vernova stock has outperformed the other renewable energy stocks over the past year, while analysts remain fairly bullish about its prospects.
Via Barchart.com · December 8, 2025

DoorDash has outperformed the Dow over the past year, and analysts are highly optimistic about the stock’s prospects.
Via Barchart.com · December 8, 2025
Via Benzinga · December 8, 2025
Via Benzinga · December 8, 2025
Via Benzinga · December 8, 2025
Via Benzinga · December 8, 2025
Via Benzinga · December 8, 2025
Via Benzinga · December 8, 2025
Via Benzinga · December 8, 2025
Via Benzinga · December 8, 2025
Via Benzinga · December 8, 2025
Gold remains firmly bullish, holding above $4220 with momentum indicators supportive of further gains.
Via Talk Markets · December 8, 2025
Via Benzinga · December 8, 2025
Via Benzinga · December 8, 2025
Via Benzinga · December 8, 2025
Via Benzinga · December 8, 2025
The surplus in the oil market is set to grow in 2026, following OPEC+'s decision to unwind supply cuts at a quicker-than-expected pace.
Via Talk Markets · December 8, 2025
Why Did Structure Therapeutics Stock Surge Pre-Market Today?stocktwits.com
Via Stocktwits · December 8, 2025
Paramount launched an all-cash tender offer to acquire Warner Bros. for $30/share, valuing the company at $108.4B and promising $6B+ in cost synergies.
Via Benzinga · December 8, 2025
Investor confidence in the crypto mining space, and Bitfarms, appears to be on shakier ground this week.
Via The Motley Fool · December 8, 2025
Archer-Daniels-Midland has outperformed the Consumer Staples sector over the past year, but analysts are cautious about the stock’s prospects.
Via Barchart.com · December 8, 2025
Kymera Therapeutics released positive clinical results for KT-621 for atopic dermatitis and other allergic diseases.
Via Benzinga · December 8, 2025
The AUD/USD outlook remains constructive as the US dollar weakens ahead of the Fed rate cut.
Via Talk Markets · December 8, 2025
There's no point in life when your credit score stops mattering.
Via The Motley Fool · December 8, 2025
Xcel Energy has underperformed the S&P 500 over the past year, but analysts are highly optimistic about the stock’s prospects.
Via Barchart.com · December 8, 2025
Rosenblatt Securities downgraded Netflix to ‘Neutral’ from ‘Buy’, citing concerns about the uncertainty and risks following the acquisition.
Via Stocktwits · December 8, 2025
Elon Musk nixes reports that SpaceX is targeting an $800 billion valuation via a secondary stock sale. But is a 2026 IPO in play?
Via Investor's Business Daily · December 8, 2025
Via Benzinga · December 8, 2025
Via Benzinga · December 8, 2025
Tractor Supply has underperformed the Nasdaq over the past year, but analysts are cautiously optimistic about the stock’s prospects.
Via Barchart.com · December 8, 2025
Wave Life Sciences stock shot a year-high Monday on promising results for an entirely new drug that could target fat loss.
Via Investor's Business Daily · December 8, 2025
Coinbase Inc.
Via Benzinga · December 8, 2025
Despite Dollar General's strong performance relative to the broader Nasdaq Composite over the past year, Wall Street analysts maintain a cautiously optimistic outlook on the stock’s prospects.
Via Barchart.com · December 8, 2025
These three dividend stocks are poised to rally in the new year.
Via The Motley Fool · December 8, 2025